A micro costing of NHS cancer genetic services

British Journal of Cancer

Volumn 92, Issue 1, 2005, Pages 60-71

  Griffith, G L ^a   Tudor Edwards, R ^a   Gray, J ^b   Butler, R ^b   Wilkinson, C ^c   Turner, J ^c   France, B ^c   Bennett, P ^d  

^a BANGOR UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Breast; Colorectal; Cost; Genetic; Ovarian

Indexed keywords

ACCOUNTING; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER GENETICS SERVICE; CLINICAL PATHWAY; CLINICAL PROTOCOL; COLORECTAL CANCER; COST BENEFIT ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE COST; HEALTH CARE NEED; HIGH RISK PATIENT; LABOR COST; MEDICAL PERSONNEL; MICROCOSTING; NATIONAL HEALTH SERVICE; OVARY CANCER; PRIORITY JOURNAL; UNITED KINGDOM; WORKING TIME;

COSTS AND COST ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC COUNSELING; GENETIC SERVICES; GREAT BRITAIN; HEALTH PERSONNEL; HUMANS; LABORATORIES; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NEOPLASMS; REFERRAL AND CONSULTATION; RISK ASSESSMENT;

EID: 13244249622     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602270     Document Type: Article

References (26)

1. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomak P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP, de la Chapelle A, Percesepe A, Ahtola H, Harkonen N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E (1998) Incidence of hereditary nonpolyposis cancer and the feasibility of molecular screening for the disease. N Engl J Med 338(21):1481-1487
2. Audrain J, Schwarts MD, Lerman C, Hughes C, Peshkin BN, Biesecker B (1998) Psychological distress in women seeking genetic counselling for breast ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med 19: 370-377
3. Brain K, Gray J, Norman P, Parsons E Clarke A, Rogers C, Mansel R, Harper P (2000) Why do women attend familial breast cancer clinics? J Med Genet 37: 1-5
4. Brown ML, Kessler LG (1995) The use of gene tests to detect hereditary predisposition to cancer: Economic considerations. J Natl Cancer Inst 87: 1131-1136
5. Brown ML, Kessler LG (1996) Use of gene tests to detect hereditary predisposition to cancer: What do we know about cost-effectiveness? Int J Cancer 69: 55-57
6. Clarke S, Bluman LG, Borstelmann N, Regan K, Winer EP, Rimer BK, Skinner CS (2001) Patient motivation, satisfaction and coping in genetic counseling and testing for BRCA1 and BRCA2. Journal of Genetic Counseling 9: 219-235
7. Committee for Medical Genetics Workload Units Working Group (2002) CMGS Workload Units: Proposed Scheme. The Committee for Medical Genetics
8. Fry A, Cull A, Appleton S, Rush R, Holloway S, Gorman D, Cetnarskyj R, Thomas R, Campbnell J, Anderson E, Steel M, Porteous M, Campbell H (2003) A randomised control treial of breast cancer genetics services in South East Scotland: Psychologicxal impact. Br J Cancer 89: 653-659
9. Geer KP, Ropka ME, Cohn WF, Jones SM, Miesfeldt S (2001) Factors influencing patients' decisions to decline cancer genetic counselling services. Journal of Genetic Counseling 10: 25-40
10. Griffith GL, Edwards RT, Gray J (2004) Cancer Genetics Services: A Review of the Economic Evidence and Issues. Br J Cancer 90: 1697-1703
11. Grosfeld FJM, Lips CJM, Beemer FA, ten Kroode HFJ (2000) Who is at risk for psychological distress in genetic testing programs for hereditary cancer disorders? Journal of Genetic Counseling 9(3): 253-266
12. Jacobs I, Mackay J, Menon U, Skates S (2000) UK Familial Ovarian Cancer Screening Study: Study Protocol. Cancer Research UK and University College London Cancer Trials Centre http://www.ncrn.org.uk/portfolio/data.asp?ID = 1069
13. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics. CA Cancer J Clin 49: 8-31
14. Lerman C (1997) Translational behavioural research in cancer genetics. Preventative Medicine 26: S65-S69
15. Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, Norad S, Lynch HT (1998) What you don't know can hurt you: adverse psychological effects in members of BRCA1-linked and BRCA2-linked families who declined genetic testing. J Clin Oncol 16: 1650-1654
16. Lerman C, Schwartz MD, Lin TH, Hughes C, Norad S, Lynch HT (1997) The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 65(3): 414-420
17. Lynch HT, Albano WA, Danes BS, Layton MA, Kimberling WJ, Lynch JF, Cheng SC, Costello KA, Mulcahy GM, Wagner CA, Tindall SL (1984) Genetic predisposition to breast cancer. Cancer 53: 612-622
18. Malanders S, Ridderheim M, Masback A, Loman N, Kristoffersson U, Olsson H, Nibert M, Boirg A (2004) One in 10 ovarian cancer patients carry germline BRCA1 or BRCA2 mutations. Results of a prospective study in Southern Sweden. Eur J Cancer 40(3): 422-428
19. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonnin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71
20. Netten A, Curtis L (2003) Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury
21. Ponder BAJ (1999) Costs, benefits and limitations of genetic testing for cancer risk. Br J Cancer 80(Supplement 1): 46-50
22. Rees G, Fry A, Cul A (2001) A family history of breast cancer: women's experiences from a theoretical perspective. Soc Sci Med 52: 1433-1440
23. Risch HA, McLaughlin JR, Cole DEC, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JLA, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in population series of 649 women with ovarian cancer. Am J Hum Genet 68: 700-711
24. Soravia C, Bapat B, Cohen Z (1997) Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects. Schweiz Med Wochenschr 127: 682-690
25. Steel M, Smyth E, Vasen H, Eccles D, Evans G, Moller P, Hodgson S, Stoppa-Lyonnet D, Chang-Claude J, Caligo M, Morrison P, Haites N (1999) Ethical, social and economic issues in familial breast cancer: A compilation of views from the E.G. Biomed II Demonstration project. Dis Markers 15: 125-131
26. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792